Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Nrti'
Nrti published presentations and documents on DocSlides.
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
by maximus
DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
by roxanne
FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
by lucy
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
by kylie
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
A nti- R etroviral T herapy Basics
by caroline
E Duke. https://www.hiv.uw.edu/page/treatment/drug...
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Lopinavir -RTV + NVP +
by thomas
2 NRTIs in Treatment-Experienced. M97-765 Trial. L...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
Switch a ATV/r 3TC Estudio ATLAS-M
by pamella-moone
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
Superior Efficacy of Dolutegravir (DTG) Plus
by celsa-spraggs
2 Nucleoside Reverse Transcriptase Inhibitors (NR...
ART Resistance and Second Line Regimens
by calandra-battersby
Learning Objectives. Understand when to switch to...
Management of NRTI Resistance
by giovanna-bartolotta
David Spach, MD. Principal . Investigator, NW AET...
Comparison of NNRTI vs PI/r
by alexa-scheidler
EFV vs LPV/r vs EFV + LPV/r . A5142. Mexican. . ...
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...
Switch PI/R to ETR Etraswitch
by dustin869
Etraswitch. . Study. : Switch PI/r to ETR. Contin...
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Dolutegravir ( Tivicay )
by brown
Prepared by:. Brian R. Wood, MD. David H. Spach, M...
Dolutegravir vs. Raltegravir
by zoe
SPRING-2 Study. Dolutegravir. versus Raltegravir....
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
by taylor
Supported by an educational grant from Gilead Scie...
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Zidovudine Retrovir AZT Class Zidovudine is a thymidine analog
by mackenzie
Disease state based dosing: Clcr 10 mL/min...
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
ART in Women and Contraception: InSTIs
by olivia-moreira
ART in Women and Contraception: InSTIs , Comorbi...
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
Ellen G. Chadwick, MD Professor of Pediatrics
by mitsue-stanley
Northwestern University Feinberg School of Medici...
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Updated WHO Treatment Guidelines &
by mitsue-stanley
Data . from other . cohorts and . regions to guid...
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
by luanne-stotts
Chief, Division of Infectious Diseases. Weill Med...
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Comparison of NRTI combinations
by tawny-fly
ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...
Load More...